Amyloidosis Clinical Trials in Pavia
16 recruitingPavia, Italy
Showing 1–16 of 16 trials
Recruiting
Phase 3
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Hereditary Transthyretin-Mediated Amyloidosis With PolyneuropathyhATTR-PN
Alnylam Pharmaceuticals125 enrolled29 locationsNCT07223203
Recruiting
Phase 3
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Alnylam Pharmaceuticals1,250 enrolled233 locationsNCT07052903
Recruiting
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
PolyneuropathyHereditary Transthyretin-mediated (hATTR) Amyloidosis
Alnylam Pharmaceuticals10 enrolled7 locationsNCT05040373
Recruiting
Phase 1Phase 2
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Immunoglobulin Light Chain (AL) Amyloidosis
AbbVie76 enrolled23 locationsNCT06158854
Recruiting
Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company587 enrolled101 locationsNCT06563895
Recruiting
One Gene, Two Diseases: the Pathologic Role of IGLV1-44 in AL Amyloidosis and POEMS
Multiple MyelomaAL AmyloidosisPOEMS Syndrome
Fondazione IRCCS Policlinico San Matteo di Pavia100 enrolled1 locationNCT07448935
Recruiting
Phase 2
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
AL Amyloidosis
European Myeloma Network B.V.30 enrolled10 locationsNCT06649695
Recruiting
A Registry of AL Amyloidosis (ReAL)
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia5,000 enrolled1 locationNCT04839003
Recruiting
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaAL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia760 enrolled4 locationsNCT06383143
Recruiting
A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia400 enrolled6 locationsNCT06205953
Recruiting
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
AmyloidosisAmyloidosis CardiacATTR Amyloidosis Wild Type
Paolo Milani200 enrolled1 locationNCT06251778
Recruiting
Phase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Intellia Therapeutics1,200 enrolled132 locationsNCT06128629
Recruiting
The Italian Transthyretin Amyloidosis Web-Network
ATTR Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia1,000 enrolled30 locationsNCT05444920
Recruiting
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Hereditary Transthyretin Amyloidosis With Polyneuropthy
Akcea Therapeutics240 enrolled26 locationsNCT04850105
Recruiting
Not Applicable
Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL Amyloidosis
AL Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia69 enrolled1 locationNCT04392960
Recruiting
Not Applicable
An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy
Hereditary Transthyretin Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia150 enrolled1 locationNCT06907186